BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15946025)

  • 1. Phosphatidylinositol-linked red blood cell membrane proteins and blood group antigens.
    Telen MJ
    Immunohematology; 1991; 7(3):65-72. PubMed ID: 15946025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins.
    Telen MJ; Rosse WF; Parker CJ; Moulds MK; Moulds JJ
    Blood; 1990 Apr; 75(7):1404-7. PubMed ID: 2317557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol-glycan linked proteins of the erythrocyte membrane.
    Telen MJ; Rosse WF
    Baillieres Clin Haematol; 1991 Dec; 4(4):849-68. PubMed ID: 1724205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
    Lin LI; Chen YC; Lin JK
    Hematology; 1997; 2(5):399-406. PubMed ID: 27405407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal nocturnal hemoglobinuria and complement-mediated erythrocyte damage.
    Parker CJ
    Curr Opin Hematol; 1994 Mar; 1(2):151-6. PubMed ID: 9371274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cromer-related blood group antigens and the glycosyl phosphatidylinositol-linked protein, decay-accelerating factor DAF (CD55).
    Reid ME
    Immunohematology; 1990; 6(2):27-9. PubMed ID: 15945985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of intravascular hemolysis in paroxysmal nocturnal hemoglobinuria (PNH).
    Nakakuma H
    Am J Hematol; 1996 Sep; 53(1):22-9. PubMed ID: 8813092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations using a novel monoclonal antibody to the glycosylphosphatidylinositol-anchored protein that carries Gregory, Holley, and Dombrock blood group antigens.
    Rao N; Udani M; Nelson J; Reid ME; Telen MJ
    Transfusion; 1995 Jun; 35(6):459-64. PubMed ID: 7770894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
    Edberg JC; Salmon JE; Whitlow M; Kimberly RP
    J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of the JMH antigen on a novel phosphatidylinositol-linked human membrane protein.
    Bobolis KA; Moulds JJ; Telen MJ
    Blood; 1992 Mar; 79(6):1574-81. PubMed ID: 1372190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group antigens as tumor markers, parasitic/bacterial/viral receptors, and their association with immunologically important proteins.
    Garratty G
    Immunol Invest; 1995; 24(1-2):213-32. PubMed ID: 7713584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
    Mevorach D
    Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of paroxysmal nocturnal hemoglobinuria.
    Krauss JS
    Ann Clin Lab Sci; 2003; 33(4):401-6. PubMed ID: 14584753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in research on paroxysmal nocturnal hemoglobinuria].
    Kinoshita T
    Rinsho Ketsueki; 1993 May; 34(5):529-36. PubMed ID: 8315823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.
    Szer J; Hill A; Weitz IC
    Clin Adv Hematol Oncol; 2012 Nov; 10(11 Suppl 21):1-16. PubMed ID: 23271156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD59: A long-known complement inhibitor has advanced to a blood group system.
    Weinstock C; Anliker M; von Zabern I
    Immunohematology; 2015; 31(4):145-51. PubMed ID: 27187193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of paroxysmal nocturnal hemoglobinuria.
    Rosti V
    Haematologica; 2000 Jan; 85(1):82-7. PubMed ID: 10629597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.